| AstraZeneca plc. (8/21/19). "Press Release: Update on the Phase III NEPTUNE Trial of Imfinzi plus Tremelimumab in Stage IV Non-small Cell Lung Cancer". |
2019-08-21 |
| Rexgenero. (8/21/19). "Press Release: Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies". London. |
2019-08-21 |
| Medicines and Healthcare Products Regulatory Agency (MHRA). (8/20/19). "Press Release: Dr June Raine to Become Interim Chief Executive Officer". |
2019-08-20 |
| Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. |
2019-08-19 |
| Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. |
2019-08-19 |
| Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-08-16 |
| Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. |
2019-08-13 |
| University College London (UCL). (8/13/19). "Press Release: Biotech Startup Secures £6.5m for Dementia Research". |
2019-08-13 |
| GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. |
2019-08-12 |
| Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. |
2019-08-12 |
| Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board". |
2019-08-12 |
| Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. |
2019-08-12 |
| Start Codon Ltd.. (8/9/19). "Press Release: Start Codon Partners with Clustermarket and Science Entrepreneur Club to Support Life Science and Healthcare Start-ups". Cambridge. |
2019-08-09 |
| MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-08 |
| Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. |
2019-08-08 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. |
2019-08-07 |
| MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. |
2019-08-07 |
| IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". |
2019-08-07 |
| TopiVert Pharma Ltd.. (8/7/19). "Press Release: TopiVert Announces Top-Line Results from THEIA-1 Phase 2b/3 Clinical Study of TOP1630 as a Treatment for Dry Eye Disease". London. |
2019-08-07 |
| Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. |
2019-08-06 |
| BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv. |
2019-08-06 |
| Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. |
2019-08-05 |
| Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA. |
2019-08-05 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. |
2019-08-05 |
| Exscientia Ltd.. (8/5/19). "Press Release: Sanofi Exercises Option on Exscientia-designed Bispecific Small Molecule for Treatment of Immunological Conditions". |
2019-08-05 |
| Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. |
2019-08-01 |
| Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. |
2019-08-01 |
| Atlantic Healthcare plc. (7/31/19). "Press Release: Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis". Cambridge. |
2019-07-31 |
| Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". |
2019-07-31 |
| PredictImmune Ltd.. (7/30/19). "Press Release: PredictImmune Closes Series B Funding Round, Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline". Cambridge. |
2019-07-30 |
| Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. |
2019-07-29 |
| Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. |
2019-07-25 |
| Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. |
2019-07-23 |
| Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. |
2019-07-22 |
| Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. |
2019-07-19 |
| Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. |
2019-07-18 |
| Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. |
2019-07-18 |
| Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. |
2019-07-18 |
| Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. |
2019-07-18 |
| Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. |
2019-07-16 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. |
2019-07-16 |
| Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. |
2019-07-15 |
| Healx Ltd.. (7/11/19). "Press Release: Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion". |
2019-07-11 |
| Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. |
2019-07-10 |
| Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London. |
2019-07-10 |
| BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. |
2019-07-09 |
| Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. |
2019-07-09 |
| PhoreMost Ltd.. (7/8/19). "Press Release: PhoreMost and inStem Enter Structural Biology Alliance". Cambridge. |
2019-07-08 |
| Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. |
2019-07-08 |
| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
| Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". |
2019-07-08 |
| Evotec SE. (7/8/19). "Press Release: Evotec and Venture Capital Consortium Form Breakpoint Therapeutics GmbH". Hamburg. |
2019-07-08 |
| Nosopharm S.A.S.. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. |
2019-07-03 |
| GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. |
2019-07-03 |
| MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg. |
2019-07-03 |
| GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. |
2019-07-03 |
| Cancer Research UK. (7/2/19). "Press Release: Cancer Research UK Forms Collaboration with SV Health Investors to Accelerate Development of Cancer Medicines". |
2019-07-02 |
| Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. |
2019-07-02 |
| Antibodies.com. (7/2/19). "Press Release: Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less". Cambridge. |
2019-07-02 |
| ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". |
2019-07-01 |
| [iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. |
2019-07-01 |
| X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. |
2019-07-01 |
| Ahren Innovation Capital LLP. (7/1/18). "Press Release: Ahren Announces Fund Close". |
2019-07-01 |
| Community for Analytical Measurement Science. (6/28/19). "Press Release: Community for Analytical Measurement Science Celebrates Its Launch". London. |
2019-06-28 |
| Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. |
2019-06-28 |
| Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire. |
2019-06-27 |
| Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. |
2019-06-27 |
| Cobra Biologics Ltd.. (6/25/19). "Press Release: Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration". Keele & Stirling. |
2019-06-25 |
| Genedata AG. (6/25/19). "Press Release: Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis". Basel. |
2019-06-25 |
| Kymab Ltd.. (6/24/19). "Press Release: Kymab and LifeArc Enter Strategic Partnership to Discover New Medicines Using Kymab’s IntelliSelect Technologies". Cambridge. |
2019-06-24 |
| GlaxoSmithKline plc. (6/24/19). "Press Release: U.S. Food and Drug Administration Accepts GSK’s Application for Zejula (niraparib) in Late Stage Ovarian Cancer with Priority Review". London. |
2019-06-24 |
| Oxford Immunotec Global plc. (6/24/19). "Press Release: Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman". Oxford & Marlborough, MA. |
2019-06-24 |
| Arcus Biosciences, Inc.. (6/24/19). "Press Release: Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer". Hayward, CA. |
2019-06-24 |
| Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". |
2019-06-21 |
| Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. |
2019-06-20 |
| BioCity Group Ltd.. (6/18/19). "Press Release: New Carbon Capture Technology Could Help Industry and Agricultural Sector Decarbonise". |
2019-06-18 |
| Illumina, Inc.. (6/17/19). "Press Release: Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. |
2019-06-17 |
| GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. |
2019-06-13 |
| Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". |
2019-06-12 |
| Ligand Pharmaceuticals Inc.. (6/12/19). "Press Release: Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology". San Diego, CA & Cambridge. |
2019-06-12 |
| Exscientia Ltd.. (6/11/19). "Press Release: Exscientia Expands International Collaborations with Shanghai-headquartered GT Apeiron Therapeutics". Oxford. |
2019-06-11 |
| Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. |
2019-06-10 |
| Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. |
2019-06-07 |
| BioCity Group Ltd.. (6/7/19). "Press Release: New Contract Research Organisation for Platelet Testing". |
2019-06-07 |
| Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. |
2019-06-04 |
| LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen. |
2019-06-03 |
| University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". |
2019-05-31 |
| Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. |
2019-05-30 |
| [iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme |
2019-05-30 |
| BRAIN AG. (5/29/19). "Press Release: BRAIN AG Achieves Significant Growth in the First Half of the 2018/19 Financial Year". Zwingenberg. |
2019-05-29 |
| Kintai Therapeutics, Inc.. (5/29/19). "Press Release: Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board". Cambridge, MA. |
2019-05-29 |
| Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. |
2019-05-28 |
| Sciad Communications. (5/24/19). "Press Release: Sold Out Inaugural Bio Integrates Conference a Resounding Success". London. |
2019-05-24 |
| Satellite Applications Catapult. (5/23/19). "Press Release: Innovative Partnership to Embed the Power of Satellite Technology in Digitally Enabled Care". |
2019-05-23 |
| Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. |
2019-05-20 |
| Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. |
2019-05-20 |
| LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment". |
2019-05-20 |
| King’s College London. (5/20/19). "Press Release: Quell Therapeutics Ltd Founded for Emerging Area of Cell Therapy". |
2019-05-20 |
| Biosynth AG. (5/20/19). "Press Release: Biosynth and Carbosynth Merge to Form a Leading Player in the Global Fine Chemicals Market". Staad & Compton. |
2019-05-20 |
| ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. |
2019-05-15 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
Date![[iito] Business Intelligence – The Elephants Are Coming 560x91px](/banner/iito-20190816-650-091-youtube-video-the-elephants-are-coming-telegram.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
